MeiraGTx Holdings (MGTX) Cash & Equivalents (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Cash & Equivalents of $65.9 million for Q4 2025, down 36.4% on a YoY basis from $103.7 million in Q4 2024, and up 344.25% quarter-over-quarter from $14.8 million in Q3 2025.
MeiraGTx Holdings (MGTX) Cash & Equivalents (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Cash & Equivalents for 9 years, with the latest figure at $65.9 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents fell 36.4% year-over-year to $65.9 million; the trailing twelve-month figure through Dec 2025 stood at $65.9 million (down 36.4% YoY), and the FY2025 full-year result was $65.9 million, down 36.4% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $65.9 million, up from $14.8 million in the prior quarter.
- The five-year high for Cash & Equivalents was $199.4 million in Q1 2021, with the low at $14.8 million in Q3 2025.
- Historically, Cash & Equivalents has averaged $102.8 million across 5 years, with a median of $108.7 million in 2022.
- Annual changes were most pronounced in 2024 — Cash & Equivalents surged 94.14% — and 2025, when it tumbled 88.13%.
- MeiraGTx Holdings' Cash & Equivalents stood at $137.7 million in 2021, then retreated by 16.11% to $115.5 million in 2022, then increased by 13.1% to $130.6 million in 2023, then slipped by 20.66% to $103.7 million in 2024, then plunged by 36.4% to $65.9 million in 2025.
- The last three Cash & Equivalents figures came in at $65.9 million (Q4 2025), $14.8 million (Q3 2025), and $32.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 558.94 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 65.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.93 Mn |
| Sep 30, 2025 | 14.84 Mn |
| Jun 30, 2025 | 32.17 Mn |
| Mar 31, 2025 | 66.52 Mn |
| Dec 31, 2024 | 103.66 Mn |
| Sep 30, 2024 | 125.03 Mn |
| Jun 30, 2024 | 101.03 Mn |
| Mar 31, 2024 | 120.27 Mn |
| Dec 31, 2023 | 130.65 Mn |
| Sep 30, 2023 | 64.40 Mn |
| Jun 30, 2023 | 92.77 Mn |
| Mar 31, 2023 | 68.78 Mn |
| Dec 31, 2022 | 115.52 Mn |
| Sep 30, 2022 | 114.71 Mn |
| Jun 30, 2022 | 72.11 Mn |
| Mar 31, 2022 | 113.78 Mn |
| Dec 31, 2021 | 137.70 Mn |
| Sep 30, 2021 | 143.63 Mn |
| Jun 30, 2021 | 172.56 Mn |
| Mar 31, 2021 | 199.41 Mn |